Shalby [SHALBY] vs Dr. Agarwal's Eye [DRAGARWQ] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Shalby Ltd. wins in 6 metrics, Dr. Agarwal's Eye Hospital Ltd. wins in 14 metrics, with 0 ties. Dr. Agarwal's Eye Hospital Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Shalby Ltd. | Dr. Agarwal's Eye Hospital Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 207.28 | 34.01 | Dr. Agarwal's Eye Hospital Ltd. |
| Price-to-Book Ratio | 1.75 | 7.52 | Shalby Ltd. |
| Debt-to-Equity Ratio | 53.32 | 106.45 | Shalby Ltd. |
| PEG Ratio | -1.45 | 1.81 | Dr. Agarwal's Eye Hospital Ltd. |
| EV/EBITDA | 16.45 | 20.64 | Shalby Ltd. |
| Profit Margin (TTM) | 0.72% | 15.50% | Dr. Agarwal's Eye Hospital Ltd. |
| Operating Margin (TTM) | 4.65% | 19.54% | Dr. Agarwal's Eye Hospital Ltd. |
| EBITDA Margin (TTM) | 4.65% | 19.54% | Dr. Agarwal's Eye Hospital Ltd. |
| Return on Equity | 0.63% | 26.07% | Dr. Agarwal's Eye Hospital Ltd. |
| Return on Assets (TTM) | 0.37% | 8.91% | Dr. Agarwal's Eye Hospital Ltd. |
| Free Cash Flow (TTM) | $-757.89M | $-83.80M | Dr. Agarwal's Eye Hospital Ltd. |
| Dividend Yield | 0.65% | 0.11% | Shalby Ltd. |
| 1-Year Return | -6.18% | 12.35% | Dr. Agarwal's Eye Hospital Ltd. |
| Price-to-Sales Ratio (TTM) | 1.55 | 5.39 | Shalby Ltd. |
| Enterprise Value | $22.59B | $26.69B | Dr. Agarwal's Eye Hospital Ltd. |
| EV/Revenue Ratio | 2.02 | 5.92 | Shalby Ltd. |
| Gross Profit Margin (TTM) | 41.11% | 78.09% | Dr. Agarwal's Eye Hospital Ltd. |
| Revenue per Share (TTM) | $101 | $952 | Dr. Agarwal's Eye Hospital Ltd. |
| Earnings per Share (Diluted) | $0.78 | $147.68 | Dr. Agarwal's Eye Hospital Ltd. |
| Beta (Stock Volatility) | 0.47 | -0.57 | Dr. Agarwal's Eye Hospital Ltd. |
Shalby Ltd. vs Dr. Agarwal's Eye Hospital Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Shalby Ltd. | 1.00% | -0.43% | 7.91% | 21.73% | -12.46% | -15.93% |
| Dr. Agarwal's Eye Hospital Ltd. | 0.58% | 0.12% | -1.62% | 6.94% | -8.52% | -6.31% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Shalby Ltd. | -6.18% | 10.56% | 5.52% | -29.49% | -29.49% | -29.49% |
| Dr. Agarwal's Eye Hospital Ltd. | 12.35% | 240.02% | 1,131.89% | 2,480.68% | 5,282.48% | 17,498.05% |
Performance & Financial Health Analysis: Shalby Ltd. vs Dr. Agarwal's Eye Hospital Ltd.
| Metric | SHALBY | DRAGARWQ |
|---|---|---|
| Market Information | ||
| Market Cap | ₹16.70B | ₹24.28B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 80,346 | 1,256 |
| 90 Day Avg. Volume | 143,083 | 1,378 |
| Last Close | ₹170.62 | ₹4,991.20 |
| 52 Week Range | ₹125.82 - ₹274.70 | ₹4,142.00 - ₹6,392.00 |
| % from 52W High | -37.89% | -21.91% |
| All-Time High | ₹339.50 (Jan 22, 2024) | ₹7,300.00 (Dec 30, 2024) |
| % from All-Time High | -49.74% | -31.63% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.01% | 0.22% |
| Quarterly Earnings Growth | -0.01% | 0.66% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.16% |
| Operating Margin (TTM) | 0.05% | 0.20% |
| Return on Equity (TTM) | 0.01% | 0.26% |
| Debt to Equity (MRQ) | 53.32 | 106.45 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹92.31 | ₹668.22 |
| Cash per Share (MRQ) | ₹1.77 | ₹191.98 |
| Operating Cash Flow (TTM) | ₹-417,020,000 | ₹738.70M |
| Levered Free Cash Flow (TTM) | ₹62.22M | ₹546.50M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.65% | 0.11% |
| Last 12-Month Dividend | ₹1.20 | ₹5.00 |
Valuation & Enterprise Metrics Analysis: Shalby Ltd. vs Dr. Agarwal's Eye Hospital Ltd.
| Metric | SHALBY (Apr 24, 2026) | DRAGARWQ (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 207.28 | 34.01 |
| Forward P/E | 17.20 | 516.77 |
| PEG Ratio | -1.45 | 1.81 |
| Price to Sales (TTM) | 1.55 | 5.39 |
| Price to Book (MRQ) | 1.75 | 7.52 |
| Market Capitalization | ||
| Market Capitalization | ₹16.70B | ₹24.28B |
| Enterprise Value | ₹22.59B | ₹26.69B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.02 | 5.92 |
| Enterprise to EBITDA | 16.45 | 20.64 |
| Risk & Other Metrics | ||
| Beta | 0.47 | -0.57 |
| Book Value per Share (MRQ) | ₹92.31 | ₹668.22 |
Financial Statements Comparison: Shalby Ltd. vs Dr. Agarwal's Eye Hospital Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | SHALBY (2025) | DRAGARWQ (2025) |
|---|---|---|
| Revenue/Sales | 10.81B | 3.94B |
| Cost of Goods Sold | 6.35B | 896.20M |
| COGS % of Revenue | 58.8% | 22.8% |
| Gross Profit | 4.46B | 3.04B |
| Gross Margin | 41.2% | 77.2% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 779.43M | 813.30M |
| Operating Margin | 7.2% | 20.6% |
| EBITDA | 1.51B | 1.22B |
| EBITDA Margin | 14.0% | 31.1% |
| Pre-Tax Income | 557.29M | 707.00M |
| Pre-Tax Income % of Revenue | 5.2% | 17.9% |
| Income Tax | 538.09M | 160.50M |
| Income Tax % of Revenue | 5.0% | 4.1% |
| Net Income (Profit) | 19.20M | 546.50M |
| Profit Margin | 0.2% | 13.9% |
Balance Sheet & Liquidity Metrics
| Metric | SHALBY (2025) | DRAGARWQ (2025) |
|---|---|---|
| Cash & Equivalents | 347.85M | 111.60M |
| Total Current Assets | 6.58B | 559.40M |
| Total Current Assets % of Revenue | 60.9% | 14.2% |
| Total Current Liabilities | 4.55B | 869.80M |
| Total Current Liabilities % of Revenue | 42.1% | 22.1% |
| Long-Term Debt | 1.75B | 3.06B |
| Long-Term Debt % of Revenue | 16.2% | 77.6% |
| Total Shareholders Equity | 9.95B | 2.10B |
| Retained Earnings | 4.44B | 1.99B |
| Retained Earnings % of Revenue | 41.1% | 50.4% |
| Property, Plant & Equipment | 4.36B | 1.37B |
Cash Flow Statement Comparison
| Metric | SHALBY (2025) | DRAGARWQ (2025) |
|---|---|---|
| Operating Cash Flow | -417.02M | 738.70M |
| Operating Cash Flow % of Revenue | -3.9% | 18.8% |
| Capital Expenditures | -700.85M | 4.10M |
| Free Cash Flow | -757.89M | -83.80M |
| FCF Margin | -7.0% | -2.1% |
| Debt Repayment | -393.05M | -111.30M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SHALBY | DRAGARWQ |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 107.30M | 4.83M |
| Float Shares | 26.51M | 1.08M |
| % Held by Insiders | 76.11% | 77.59% |
| % Held by Institutions | 0.07% | 3.57% |
| % Held by Public | 23.82% | 18.84% |
Dividend Analysis & Yield Comparison: Shalby Ltd. vs Dr. Agarwal's Eye Hospital Ltd.
| Metric | SHALBY | DRAGARWQ |
|---|---|---|
| Last 12-Month Dividend | ₹1.20 | ₹5.00 |
| Last 12-Month Dividend Yield | 0.65% | 0.11% |
| 3-Year Avg Annual Dividend | ₹1.08 | ₹4.50 |
| 3-Year Avg Dividend Yield | 0.55% | 0.12% |
| 3-Year Total Dividends | ₹3.23 | ₹13.50 |
| Ex-Dividend Date | Sep 19, 2024 | Nov 08, 2024 |